NERLYN COOPER: Open Payments
NPI 1760017933 · NEWTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 64 payments from 8 companies in 2025. Trend: 2023 $174 · 2024 $876 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $240 |
| Insulet Corporation | 29 | $196 |
| Corcept Therapeutics | 5 | $118 |
| Xeris Pharmaceuticals, Inc. | 5 | $92 |
| Lilly USA, LLC | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Dexcom, Inc. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: Omnipod, Ozempic, Korlym, GVOKE HYPOPEN, MOUNJARO, JARDIANCE, Rybelsus, Dexcom G6 Transmitter.
Industry payments across KS — which companies pay providers there.
